Person Dr Jayesh Desai National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects Participant in, Principal investigator of A Phase II Study of continuous, low-dose LBH 589 (Panobinostat) in Patients with Refractory Solid Tumors, including CNS tumors (funded by National Health and Medical Research Council) Participant in Centre for Translational Pathology Research and Training (funded by National Health and Medical Research Council) Participant in High-Throughput Discovery of Synergistic Drug Combinations for Metastatic Colorectal Cancer (funded by National Health and Medical Research Council) Participant in Mechanisms of Resistance to Immunological Targeting of Primary and Metastatic Colorectal Cancers (funded by National Health and Medical Research Council) Participant in Overcoming resistance to anti-EGFR antibody therapy in colorectal cancer using novel targeted PI3K and MEK inhibitors (funded by National Health and Medical Research Council) View all 7 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects Participant in, Principal investigator of A Phase II Study of continuous, low-dose LBH 589 (Panobinostat) in Patients with Refractory Solid Tumors, including CNS tumors (funded by National Health and Medical Research Council) Participant in Centre for Translational Pathology Research and Training (funded by National Health and Medical Research Council) Participant in High-Throughput Discovery of Synergistic Drug Combinations for Metastatic Colorectal Cancer (funded by National Health and Medical Research Council) Participant in Mechanisms of Resistance to Immunological Targeting of Primary and Metastatic Colorectal Cancers (funded by National Health and Medical Research Council) Participant in Overcoming resistance to anti-EGFR antibody therapy in colorectal cancer using novel targeted PI3K and MEK inhibitors (funded by National Health and Medical Research Council) View all 7 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover
